Jump to main content
Jump to site search

Issue 12, 2014
Previous Article Next Article

Pyrido- and benzisothiazolones as inhibitors of histone acetyltransferases (HATs)

Author affiliations

Abstract

Histone acetyltransferases (HATs) are interesting targets for the treatment of cancer and HIV infections but reports on selective inhibitors are very limited. Here we report structure–activity studies of pyrido- and benzisothiazolones in the in vitro inhibition of histone acetyltransferases, namely PCAF, CBP, Gcn5 and p300 using a heterogeneous assay with antibody mediated quantitation of the acetylation of a peptidic substrate. Dependent on the chemical structure distinct subtype selectivity profiles can be obtained. While N-aryl derivatives usually are rather pan-HAT inhibitors, N-alkyl derivatives show mostly a preference for CBP/p300. Selected compounds were also shown to be inhibitors of MOF. The best inhibitors show submicromolar inhibition of CBP. Selected compounds affect growth of HL-60 leukemic cells and LNCaP prostate carcinoma cells with higher potency on the leukemic cells. Target engagement was shown with reduction of histone acetylation in LNCaP cells.

Graphical abstract: Pyrido- and benzisothiazolones as inhibitors of histone acetyltransferases (HATs)

  • This article is part of the themed collection: Epigenetics
Back to tab navigation

Supplementary files

Publication details

The article was received on 10 Jun 2014, accepted on 06 Aug 2014 and first published on 11 Aug 2014


Article type: Concise Article
DOI: 10.1039/C4MD00245H
Author version
available:
Download author version (PDF)
Citation: Med. Chem. Commun., 2014,5, 1856-1862
  • Open access: Creative Commons BY license
  •   Request permissions

    Pyrido- and benzisothiazolones as inhibitors of histone acetyltransferases (HATs)

    S. D. Furdas, I. Hoffmann, D. Robaa, B. Herquel, W. Malinka, P. Świątek, A. Akhtar, W. Sippl and M. Jung, Med. Chem. Commun., 2014, 5, 1856
    DOI: 10.1039/C4MD00245H

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements